SCHEMBL1907458

SCHEMBL1907458

C[n+]1ccccc1C=Cc1ccccc1C=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.65
KMT2A Q03164 5/20 0.65
RAB9A P51151 4/20 0.65
PABPC1 P11940 2/20 0.65
APOBEC3A P31941 2/20 0.63
APOBEC3G Q9HC16 2/20 0.63
CHAT P28329 1/20 0.59
HDAC8 Q9BY41 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
CTDSP1 Q9GZU7 1/20 0.47
LMNA P02545 1/20 0.46
THRB P10828 1/20 0.46
BLM P54132 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
EIF4H Q15056 1/20 0.46
ACHE P22303 2/20 0.44
TSHR P16473 2/20 0.44
HRH1 P35367 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9951928 1.00 MEN1 (0.65) MEN1KMT2ARAB9APABPC1APOBEC3A
SCHEMBL30511472 1.00 MEN1 (0.65) MEN1KMT2ARAB9APABPC1APOBEC3A
Hydrochloric Acid SCHEMBL10347944 0.98 MEN1 (0.63) MEN1KMT2ARAB9APABPC1APOBEC3A
SCHEMBL1979985 0.79 RAB9A (0.63) MEN1KMT2ARAB9APABPC1APOBEC3A
SCHEMBL1906631 0.79 RAB9A (0.63) MEN1KMT2ARAB9APABPC1APOBEC3A
SCHEMBL29620204 0.79 RAB9A (0.63) MEN1KMT2ARAB9APABPC1APOBEC3A
SCHEMBL1426032 0.78
Iodide SCHEMBL11391939 0.77 RAB9A (0.66) MEN1KMT2ARAB9APABPC1APOBEC3A
Hydrochloric Acid SCHEMBL10675418 0.77 RAB9A (0.61) MEN1KMT2ARAB9APABPC1APOBEC3A
Hydrochloric Acid SCHEMBL10675407 0.77 RAB9A (0.61) MEN1KMT2ARAB9APABPC1APOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452211-B1 PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER OREAL (FR) 2025-12-03 EP disclosed
US-20250152495-A1 COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER HAVING A HYDROPHOBIC GROUP AND A COLORING AGENT L'OREAL (FR) 2025-05-15 US disclosed
US-20250082556-A1 PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER L'OREAL (FR) 2025-03-13 US disclosed
US-20250049696-A1 PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2025-02-13 US disclosed
EP-4452211-A1 PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER L'OREAL (FR) 2024-10-30 EP disclosed
EP-4452217-A1 PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2024-10-30 EP disclosed
WO-2024184235-A1 PROCESS FOR TREATING KERATIN FIBRES USING A CROSSLINKABLE COMPOUND, A POLYMERIC PHOTOINITIATOR AND LIGHT IRRADIATION L'OREAL (FR) 2024-09-12 WO disclosed
WO-2023117794-A1 COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER HAVING A HYDROPHOBIC GROUP AND A COLORING AGENT L'OREAL (FR) 2023-06-29 WO disclosed
WO-2023117954-A1 PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER L'OREAL (FR) 2023-06-29 WO disclosed
WO-2023118284-A1 PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2023-06-29 WO disclosed
WO-2008102144-A2 AQUEOUS FORMULATIONS AGT SCIENCES LIMITED (GB) 2008-08-28 WO disclosed
US-20070276207-A1 Polymeric Materials Incorporating a Ph Indicator Dye EAGLAND DONALD 2007-11-29 US disclosed
WO-2007132244-A2 DELIVERY MEANS AGT SCIENCES LIMITED (GB) 2007-11-22 WO disclosed
WO-2007096606-A1 DELIVERY MEANS AGT SCIENCES LIMITED (GB) 2007-08-30 WO disclosed
EP-1700115-A1 POLYMERIC MATERIALS INCORPORATING A PH INDICATOR DYE AGT Sciences Limited (GB) 2006-09-13 EP disclosed
US-20060058459-A1 Derivatised hydrogels and their use UNIVERSITY OF BRADFORD 2006-03-16 US disclosed
EP-1558652-A1 DERIVATISED HYDROGELS AND THEIR USE UNIVERSITY OF BRADFORD (GB) 2005-08-03 EP disclosed
WO-2005052572-A1 POLYMERIC MATERIALS INCORPORATING A PH INDICATOR DYE AGT SCIENCES LIMITED (GB) 2005-06-09 WO disclosed
WO-2004041872-A1 DERIVATISED HYDROGELS AND THEIR USE UNIVERSITY OF BRADFORD (GB) 2004-05-21 WO disclosed
US-4272620-A Polyvinyl alcohol-styrylpyridinium photosensitive resins and method for manufacture thereof AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1981-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049696-A1 PHOTODIMERIZABLE POLYMERS COMPRISING AT LEAST ONE POLYOXYALKYLENE GROUP, COMPOSITION COMPRISING SAME AND COSMETIC TREATMENT PROCESS KRT18, DSG1, KRTCAP2 MEN1 3364/4885KMT2A 1660/4885RAB9A 4625/4885
US-20250152495-A1 COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER HAVING A HYDROPHOBIC GROUP AND A COLORING AGENT KRT18, MAP1LC3C, KRTCAP2 MEN1 3974/4885KMT2A 810/4885RAB9A 4051/4885
US-20250082556-A1 PROCESS FOR REMOVING MAKEUP FROM KERATIN FIBRES WHICH HAVE BEEN TREATED BEFOREHAND WITH A COMPOSITION COMPRISING A PHOTOCROSSLINKABLE POLYMER KRT18, CKAP4, MARK1 MEN1 2605/4885KMT2A 1085/4885RAB9A 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.